Cite Filings / ACRS / 0001104659-24-132854
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B3

Prospectus

Aclaris Therapeutics, Inc. · Filed 2024-12-31 · Acc 0001104659-24-132854

Documents 1

  • 424B3 Prospectus , tm2432276-1_424b3.htm

Around this filing

  • 2025-01-03 4 Chief Scientific Officer gave up 41,851 shares (to pay taxes)
  • 2025-01-03 4 Chief Financial Officer gave up 38,221 shares (to pay taxes)
  • 2025-01-03 4 Chief Business Officer gave up 40,664 shares (to pay taxes)
  • 2025-01-03 4 INTERIM CEO gave up 17,436 shares (to pay taxes)
  • 2024-12-31 EFFECT Notice of Effectiveness
  • 2024-12-31 424B3 Prospectus
  • 2016-11-18 424B3 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2432276-1_424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…